Lawrence L. Gellerstedt III
Known title: DirectorCIK: 0001056731
Lawrence L. Gellerstedt III's purchase track record
How the stock did after each of Lawrence L. Gellerstedt III's open-market purchases, measured from the purchase date. Several fills within a week count as one purchase.
Purchases measured
3
of 3 since May 3, 2022
Stock higher 6 months later
67%
3 months: 100%
Median 6-month return
+3.4%
3 months: +13.0%
Beat the S&P 500
100%
median +6.0% vs. index
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 2/10/2023 | BRO | $197K | +13.0% | +21.9% | +9.1% |
| 5/19/2022 | BRO | $99K | +24.1% | +3.4% | +1.2% |
| 5/3/2022 | BRO | $200K | +5.1% | -1.7% | -7.6% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| BRO | ▲ Buy | Grant | 2,434 | $0 | 5/6/2026 | View on chart |
| BRO | ▲ Buy | Grant | 1,268 | $0 | 5/7/2025 | View on chart |
| BRO | ▲ Buy | Grant | 1,407 | $0 | 5/8/2024 | View on chart |
| BRO | ▲ Buy | Grant | 1,848 | $0 | 5/3/2023 | View on chart |
| BRO | ▲ Buy | Open Market | 3,400 | $197K | 2/10/2023 | View on chart |
| BRO | ▲ Buy | Open Market | 1,800 | $99K | 5/19/2022 | View on chart |
| BRO | ▲ Buy | Open Market | 1,690 | $100K | 5/5/2022 | View on chart |
| BRO | ▲ Buy | Grant | 1,667 | $0 | 5/4/2022 | View on chart |
| BRO | ▲ Buy | Open Market | 1,670 | $100K | 5/3/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Brown & Brown Faces Mixed Analyst Views on Valuation
Brown & Brown is seeing diverging opinions from Wall Street analysts. Wells Fargo lowered its price target to $68, citing concerns about core business weakness, while TD Cowen initiated coverage with a higher target of $82. The stock currently trades near a key support level, reflecting a market weighing these conflicting assessments of the company's value.
Brown & Brown Faces Mixed Analyst Views on Valuation. Brown & Brown is seeing diverging opinions from Wall Street analysts. Wells Fargo lowered its price target to $68, citing concerns about core business weakness, while TD Cowen initiated coverage with a higher target of $82. The stock currently trades near a key support level, reflecting a market weighing these conflicting assessments of the company's value.